REPL logo

REPL
Replimune Group Inc

3,311
Mkt Cap
$549.89M
Volume
1.2M
52W High
$14.80
52W Low
$2.68
PE Ratio
-2.19
REPL Fundamentals
Price
$7.90
Prev Close
$7.26
Open
$7.20
50D MA
$9.19
Beta
0.85
Avg. Volume
1.57M
EPS (Annual)
-$3.07
P/B
2.35
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Replimune Group (NASDAQ:REPL) Sees Large Volume Increase - Time to Buy?
Replimune Group (NASDAQ:REPL) Sees Large Volume Increase - Still a Buy...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Replimune Group (NASDAQ:REPL) Trading Down 5.4% - Should You Sell?
Replimune Group (NASDAQ:REPL) Stock Price Down 5.4% - Here's What Happened...
MarketBeat·7d ago
News Placeholder
Replimune Group, Inc. (NASDAQ:REPL) Receives Consensus Rating of "Moderate Buy" from Brokerages
Replimune Group, Inc. (NASDAQ:REPL - Get Free Report) has received an average recommendation of "Moderate Buy" from the eleven analysts that are currently covering the firm, Marketbeat.com reports...
MarketBeat·12d ago
News Placeholder
Replimune Group Sees Unusually High Options Volume (NASDAQ:REPL)
Replimune Group, Inc. (NASDAQ:REPL - Get Free Report) was the target of unusually large options trading activity on Tuesday. Investors purchased 12,092 call options on the stock. This is an increase...
MarketBeat·16d ago
News Placeholder
Replimune Group (NASDAQ:REPL) Shares Down 6.4% - What's Next?
Replimune Group (NASDAQ:REPL) Stock Price Down 6.4% - Time to Sell...
MarketBeat·20d ago
News Placeholder
Here's Why Replimune Stock Skyrockets Nearly 131% in 3 Months
REPL shares soar 131.1% over the past three months after the FDA accepts its resubmitted BLA for the RP1/Opdivo combo in advanced melanoma.
Zacks·22d ago
News Placeholder
Replimune Group (NASDAQ:REPL) Trading Up 4.8% - Should You Buy?
Replimune Group (NASDAQ:REPL) Trading 4.8% Higher - Here's Why...
MarketBeat·29d ago
News Placeholder
Replimune Group, Inc. (NASDAQ:REPL) Given Average Rating of "Moderate Buy" by Brokerages
Shares of Replimune Group, Inc. (NASDAQ:REPL - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the eleven analysts that are presently covering the stock...
MarketBeat·1mo ago
News Placeholder
Replimune Group, Inc. $REPL Holdings Trimmed by Braidwell LP
Braidwell LP lowered its holdings in Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 71.1% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange...
MarketBeat·1mo ago
News Placeholder
Replimune Group (NASDAQ:REPL) Director Kapil Dhingra Sells 3,169 Shares
Replimune Group, Inc. (NASDAQ:REPL - Get Free Report) Director Kapil Dhingra sold 3,169 shares of Replimune Group stock in a transaction dated Tuesday, December 9th. The stock was sold at an average...
MarketBeat·1mo ago
<
1
2
...
>

Latest REPL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.